Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3224-3231

  Verty, A N A ^a   McFarlane, J R ^a   McGregor, I S ^b   Mallet, P E ^a  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CANNABINOID 1 RECEPTOR; DRONABINOL; JKC 363; MELANOCORTIN 4 RECEPTOR; RECEPTOR BLOCKING AGENT; RIMONABANT; UNCLASSIFIED DRUG; 11 MRP 14 NAL 18 CYS 22 ASP BETA MSH(11 22)NH2; 11-MRP-14-NAL-18-CYS-22-ASP-BETA-MSH(11-22)NH2; BETA INTERMEDIN; CYCLOPEPTIDE; DRUG DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEEDING; FOOD INTAKE; LOCOMOTION; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG INTERACTION; EATING; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ALPHA-MSH; ANIMALS; BETA-MSH; DRUG INTERACTIONS; EATING; MALE; PEPTIDES, CYCLIC; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 3042640680     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0059     Document Type: Article

References (57)

1. Berry E, Mechoulam R 2002 Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95:185-190
2. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH 2001 The hypothalamus and the control of energy homeostasis: different circuits and different purposes. Physiol Behav 74:683-701
3. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Science 385:165-168
4. Grill HJ, Ginsberg AB, Seeley RJ, Kaplan JM 1998 Brainstem application of melanocortin receptor ligands produces long-lasting effects of feeding and body weight. J Neurosci 18:10128-10135
5. Watson SJ, Akil H 1979 The presence of two α-MSH positive cell groups in rat hypothalamus. Eur J Pharmacol 58:101-103
6. Mountjoy KG, Wong J 1997 Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol Cell Endocrinol 128:171-177
7. Huszar D, Lych CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
8. Harrold JA, Widdowson PS, Williams G 1999 Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 48:267-271
9. Poggioli R, Vergoni AV, Bertolini A 1986 ACTH-(1-24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides 7:843-848
10. Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ 1998 Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Physiol 274:R248-R254
11. Hansen MJ, Morris MJ 2002 Evidence for an interaction between neuropeptide Y and the melanocortin-4 receptor on feeding in the rat. Neuropharmacology 42:792-797
12. Kim M-S, Rossi M, Abbott CR, AlAhmed SH, Smith DM, Bloom SR 2002 Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor. Peptides 23:1069-1076
13. Koch JE 2001 Delta 9-THC stimulates food intake in Lewis rats: effects on chow, high-fat, and sweet high-fat diets. Pharmacol Biochem Behav 68:539-543
14. 9-THC. Physiol Behav 65:343-346
15. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:341-348
16. Verty ANA, McGregor IS, Mallet PE 2004 Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354:217-220
17. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G 1997 Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132: 104-106
18. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL 1998 Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci 63:PL113-PL117.
19. Simiand J, Keane M, Keane PE, Soubrié P 1998 SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179-181
20. Kirkham TC, Williams CM 2001 Endogenous cannabinoids and appetite. Nutr Res Rev 14:65-86
21. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G 2001 Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825
22. Adan RAH, Gispen WH 2000 Melanocortins and the brain: from effects via receptors to drug targets. Eur J Pharmacol 405:13-24
23. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC 1991 Characterization and localization of cannabiniod receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583
24. 9-THC induced Fos expression in rat brain. Neuropharmacology 44:264-274
25. Verty ANA, Singh ME, McGregor IS, Mallet PE, Interactive effects on food intake by cannabinoid and opioid receptors in the paraventricular hypothalamic nucleus. Proc 20th International Australasian Winter Conference on Brain Research, Queenstown, New Zealand, 2002, p 41
26. Trivedi P, Jiang M, Tamvakopoulos CC, Shen X, Yu H, Mock S, Fenyk-Melody J, Van der Ploeg LH, Guan XM 2003 Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain Res 977:221-230
27. 9- Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. Eur J Pharmacol 323:193-195
28. Corchero J, Fuentes JA, Manzanares J 1999 Chronic treatment with CP 55, 940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat. Life Sci 64:905-911
29. Cainazzo MM, Ferrazza G, Mioni C, Bazzani C, Bertolini A, Guarini S 2002 Cannabinoid CB1 receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat. Eur J Pharmacol 441:91-97
30. Verty ANA, Singh ME, McGregor IS, Mallet PE 2003 The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology 168:314-323
31. Paxinos G, Watson C 1998 The rat brain in stereotaxic coordinates. New York: Academic Press
32. Ritter RC, Slusser PG, Stone S 1981 Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213:451-452
33. Freedland CS, Poston JS, Porrino LJ 2000 Effects of SR141716A, a central cannabinoid receptor antagonist on food-maintained responding. Pharmacol Biochem Behav 67:265-270
34. Rowland NE, Mukherjee M, Robertson K 2001 Effects of cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 159:111-116
35. Abdel-Malek ZA 2001 Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58:434-441
36. Ameri A 1999 The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348
37. Daniels D, Patten CS, Roth JD, Yee DK, Fluharty SJ 2003 Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus. Brain Res 986:1-11
38. Mato S, Pazos A, Valdizan EM 2002 Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. Eur J Pharmacol 443:43-46
39. Sheriff S, Chance WT, Iqbal S, Rizvi TA, Xiao C, Kasckow JW, Balasubramaniam A 2003 Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats. Peptides 24:245-254
40. de Wied D, Jolles J 1982 Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol Behav 62:976-1059
41. Zimmermann E, Krivoy W 1973 Antagonism between morphine and the polypeptides ACTH, ACTH1-24 and β-MSH in the nervous system. Prog Brain Res 39:383-394
42. van Ree JM, Bohus B, Csontos KM, Gispen WH, Greven HM, Nijkamp FP, Opmeer FA, de Rotte GA, van Wimersma Greidanus TB, Witter A, de Wied D 1981 Behavioral profile of γ-MSH: relationship with ACTH and beta-endorphin action. Life Sci 28:2875-2878.
43. Bertolini A, Guarini S, Ferrari W, Rompianesi E 1986 Adrenocorticotropin reversal of experimental hemorrhagic shock is antagonized by morphine. Life Sci 39:1271-1280
44. Manzanares J, Corchero J, Romero J, Fernández-Ruiz JJ, Ramos JA, Fuentes JA 1999 Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287-294
45. 9-tetrahydrocannabinol stimulates palatable food intake in Lewis rats: effects of peripheral and central administration. Nutr Neurosci 4:179-187
46. Elmquist JK, Elias C, Saper C 1998 From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221-232
47. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T 1998 The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048
48. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR 2000 Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone. Diabetes 49:177-182
49. van den Pol AN 2003 Weighing the role of hypothalamic feeding neurotransmitters. Neuron 40:1059-1061
50. Kiss J, Csaki A, Bokor H, Shanabrough M, Leranth C 2000 The supramammillo-hippocampal and supramammillo-septal glutamatergic/aspartatergic projections in the rat: a combined [3H]D-aspartate autoradiographic and immunohistochemical study. Neuroscience 97:657-669
51. Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, Fujiyama F, Meister B 2003 Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. Eur J Neurosci 18:1265-1278
52. Di S, Malcher-Lopes R, Halmos KC, Tasker JG 2003 Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23:4850-4857
53. Kask A, Rago L, Korrovits P, Wikberg JE, Schioth HB 1998 Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. Biochem Biophys Res Commun 248:245-249
54. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, Palmiter RD 1999 Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21:119-122
55. Poncelet M, Maruani J, Calassi R, Soubrie P 2003 Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343:216-218
56. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW 1997 Melanocortin receptors in leptin effects. Nature 390:349
57. Kask A, Rago L, Wikberg JE, Schioth HB 1998 Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol 360:15-19